Diabetes Prevention Program Feasibility Study of Breastfeeding
Pregnancy, Overweight and Obesity

About this trial
This is an interventional treatment trial for Pregnancy focused on measuring diabetes prevention program, breastfeeding, prediabetes
Eligibility Criteria
Inclusion Criteria:
- Pregnant, 1st trimester or early 2nd trimester
- Interested in breastfeeding
- BMI >/= 25 and <35
- Able to read and understand English
- Able to learn and use Facebook
- Able to learn and use Skype, FaceTime or Zoom for virtual meetings
- Must have a cell phone
Exclusion Criteria:
- Pregnancy complications that require emergency care
- Thyroid disease
- Multiple gestation
- Substance abuse within last 3 years
- ART (Assisted Reproductive Technology) pregnancy
- Current smoker
- Prior bariatric surgery
- In weight-loss program within 3 months of conception
- BMI >/= 35
- Unable to attend intervention / follow-up visits
- Unwilling to self-monitor data collection
- Unable to complete intervention
- Presence of any condition that limits walking
- Presence of any condition that limits following diet recommendations
- Pregnancies complicated with fetuses diagnosed with lethal malformations / conditions
Sites / Locations
- Kearny County Hospital
- Via Christi Maternal Fetal Medicine Clinic
Arms of the Study
Arm 1
Arm 2
Arm 3
Active Comparator
Active Comparator
Placebo Comparator
Intervention 1 (Tx1) - DPP + Breastfeeding + Usual Care
Intervention 2 (Tx2) - DPP Only + Usual Care
Intervention 3 (Tx3) - Usual Care Only
Patients randomized to Tx1 will receive education in both the Diabetes Prevention Program (DPP) and in Breastfeeding. At baseline, this includes 16 DPP sessions (core curriculum), one 2-hour breastfeeding session, and participation in a professional peer support group. The 2-hour breastfeeding session is pre-recorded into four (4) 30-minute sessions and archived on a secure, private Facebook group. Participants will have access to all four breastfeeding sessions by week 24 of pregnancy and they need to complete all sessions by week 30 of pregnancy. At delivery, the patient will receive usual lactation support in the hospital, additional breastfeeding assessment and support (at day 3, day 10, week 3 and week 6), followed by 6 DPP sessions (post-core curriculum).
Patients randomized to Tx2 will receive education in only the Diabetes Prevention Program. At baseline, this includes 16 DPP sessions (core curriculum). At delivery, the patient will receive usual lactation support in the hospital, followed by 6 DPP sessions (post-core curriculum).
Patients randomized to Tx3 will receive only usual standard of care. At baseline, the patient will receive only regular prenatal care provided by their physician. At delivery, the patient will receive standard of care breastfeeding support provided by the hospital.